COMMUNIQUÉS West-GlobeNewswire

Editas Medicine Announces Fourth Quarter and Full Year 2018 Results and Update
28/02/2019
EDIT-101 for LCA10 set to be first ever in vivo CRISPR medicine administered to patients with dosing expected in second half of 2019 Advancing potentially best-in-class engineered cell medicine for sickle cell disease [...]
Sturdy Memorial Hospital selects Cerner EHR for cutting-edge functionality
28/02/2019
ATTLEBORO, Mass., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Sturdy Memorial Hospital (SMH) is set to upgrade its current electronic health record (EHR) with a full suite of Cerner Millennium® acute, ambulatory and revenue cycle [...]
Flexion Therapeutics Reports Fourth-Quarter and Full-Year 2018 Financial Results
28/02/2019
Company reported net ZILRETTA ® (triamcinolone acetonide extended-release injectable suspension) sales of $22.5 million for full-year 2018 Since launch, 90% of target accounts have purchased or received samples of [...]
TG Therapeutics Announces Proposed Public Offering of Common Stock and Closing of $60.0 Million Venture Debt Financing
28/02/2019
NEW YORK, Feb. 28, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), a biopharmaceutical company dedicated to developing medicines for patients with B-cell mediated diseases, today announced that it intends [...]
Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2018 Financial Results
28/02/2019
Completed rolling submission of an NDA to the U.S. FDA and an MAA to the EMA for FINTEPLA ® for the treatment of seizures associated with Dravet syndrome in February 2019 -- EMA has accepted MAA for review; outcome of [...]
Innara Health’s NTrainer System® Positively and Safely Reduces the Use of Feeding Tubes for Infants in the NICU
28/02/2019
Multicenter randomized controlled trial demonstrates 4.1-day improvement for an infant’s transition to full oral feeds and 10-day reduction in the neonatal intensive care unit (NICU) stay OLATHE, Kan., Feb. 28, 2019 ( [...]
Consolidated Sales Of Olainfarm In 2018 Exceed 124 Million, Marking The New Record
28/02/2019
Consolidated profit and loss calculation of JSC Olainfarm for 2018 shows that with the sales worth more than 124 million euros the Group has set the new annual sales record. In 2018 the net profit of Olainfarm Group [...]
ImmuCell Announces Submission of Manufacturing Technical Section for its Purified Nisin Product
28/02/2019
PORTLAND, Maine, Feb. 28, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and [...]
Dr. Mehmet Oz and Daphne Oz to host inaugural Sharecare Awards
28/02/2019
Marlo Thomas, Dr. Sanjay Gupta, American Red Cross and Atlanta Police Foundation to be recognized with special honors at celebratory event ATLANTA, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Sharecare, the digital health company [...]
Amniotic Stem Cell Co-culture System Significantly Promotes Wound Healing
28/02/2019
Merakris Therapeutics’ Lead Scientist, Sam Fagg MSc, PhD, Presents the Research Triangle Park-based Company’s Amniotic Stem Cell Co-culture RALEIGH, NC, Feb. 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Merakris [...]
VIRBAC - Mise en conformité du contrat du liquidité
28/02/2019
Le 28 février 2019 Virbac et Exane Bnp Paribas ont signé un nouveau contrat de liquidité (le « Contrat 2019 »), entré en vigueur le 1er janvier 2019, à la suite des évolutions de la réglementation applicable aux [...]
The Alliance for Regenerative Medicine Releases 2018 Annual Data Report, Highlighting Sector Trends and Metrics
28/02/2019
WASHINGTON, D.C., Feb. 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM) today announced the release of its 2018 Annual Data Report, offering an in-depth look at trends and [...]
Delcath Joins the Ocular Melanoma Community in Recognizing Rare Disease Day
28/02/2019
NEW YORK, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, highlights the experiences of [...]
PCI Biotech: Resignation of Chief Business Development Officer
28/02/2019
Oslo (Norway), 28 February 2019 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announced that its Chief Business Development Officer (CBDO), Gaël L’Hévéder has resigned and will leave PCI [...]
Hemispherx Announces Dutch Health Inspectorate Approval to Extend the Ampligen Pancreatic Cancer Early Access Program Until March 2020
28/02/2019
OCALA, Fla., Feb. 28, 2019 (GLOBE NEWSWIRE) -- (NYSE American: HEB) — Hemispherx Biopharma, Inc. (NYSE American: HEB), an immuno-pharma R&D and emerging commercial growth company focused on unmet medical needs in [...]
Chemesis in Colombia: The Place to Be for South American Cannabis, Plus Exclusive CEO Interview -- CFN Media
28/02/2019
SEATTLE, Feb. 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Abpro and NJCTTQ Enter Into Partnership for Development of Multiple Novel Bispecific Antibodies
28/02/2019
Abpro eligible to receive up to $4 billion, including $60 million in near-term R&D funding, plus potential milestones and royalties Collaboration to result in multiple new immuno-oncology bispecific therapeutic [...]
CTD Holdings Announces Grant to U.S. Non-Profit Organization to Support Patient Participation in Informational Meetings with Regulators
28/02/2019
Support is part of CTD’s efforts to recognize Rare Disease Day 2019 ALACHUA, Fla., Feb. 28, 2019 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin- [...]
Apellis Pharmaceuticals Announces Collaboration with SFJ Pharmaceuticals® for APL-2 in Hematologic Indications
28/02/2019
Apellis to receive up to $120 million in upfront and near-term milestone payments, with the potential for additional payments subject to mutual agreement Apellis retains exclusive worldwide commercial rights to APL-2 in [...]

Pages